Barron's Picks Up Wal-Mart Prescription Drug discussion

Saturday, September 23, 2006 | 09:37 AM
in Media



Our commentary Thursday on WalMart's thrust into the drugstore business (What Does Wal-Mart's Prescription Drug Plan Mean?) got a nice mention in Barron's today:

"WAL-MART DROPPED THE BOMB last week. It wasn't exactly a nuclear number, except if you happen to be Walgreen, CVS or Rite Aid, whose stocks were more or less pulverized when the mammoth merchant announced that it planned to offer generic drugs at knockdown prices (more specifically, $4 for a month's supply).

From the standpoint of the drugstore outfits -- or pharmacies, as their fans like to call them -- what the world doesn't need is another vendor of drugs. And, as the action in their shares makes painfully clear, the very last thing in the world they need is that vendor to be Wal-Mart.

It's true that Wal-Mart plans to roll out the program in stages, starting with 65 stores in Tampa, expanding its reach throughout Florida by early next year and ultimately go nationwide. It's true, too, that by no means will all generics be offered, only about 300 of the several thousand on the market; but you've got to start somewhere, and restrictive is not part of the company's lexicon.

Barry Ritholtz, the chief market strategist of the cunningly-named Ritholtz Research& Analytics, pooh-poohs the skeptics who pooh-pooh the announcement as "a mere publicity stunt in an election year" (the Dems, in case you missed it, are running against Wal-Mart as well as any stray Republicans they turn up). He points to the devastation the goliath caused among supermarkets when it moved into food retailing as a likely precursor of what may happen to the drugstore chains.

Our savvy friend Larry Feinberg, proprietor of Oracle Investment Management, which concentrates on pharmaceutical and biotech companies, sees the push by big, muscular outfits like Wal-Mart and Target to cut generic prices as bad news for a number of companies beyond the drug chains. Wal-Mart's thrust, he says, will hit such companies where it hurts most -- in their profit margins, which have been exceedingly plump.

The Wal-Mart disclosure marks, in his words, "the beginning of a period of increasing transparency -- where consumers and those that bear the freight alike will be seeking information about what the true costs of generic drugs are." And, he predicts, the disintermediation that will occur will hurt drug distributors (McKesson and Cardinal Health come to mind) as well as drug chains.

Moreover, Larry thinks the impact will be "devastating" on pharmacy-benefits managers like Medco Health Solutions, Caremark Rx and Express Scripts, some of which in some cases get the bulk of their profits from their mail-service generic drug business.

The decline, he adds, "won't happen overnight. But the die is cast."

Very cool . . .


Weirdo and Whacko
Alan Abelson
Barron's September 25, 2006

Saturday, September 23, 2006 | 09:37 AM | Permalink | Comments (27) | TrackBack (1) add to | digg digg this! | technorati add to technorati | email email this post



TrackBack URL for this entry:

Listed below are links to weblogs that reference Barron's Picks Up Wal-Mart Prescription Drug discussion:

» Wal-Mart Does Drugs from Bear Mountain Bull
This is exactly what our health care system needs - a little competition. Wal-Mart has already brought competition to the vision care world, with in-store optometrists (who will just do the exam and hand you your prescription - what a concept!), and l... [Read More]

Tracked on Sep 23, 2006 2:13:55 PM


You are my media hero. Now, why are you working on the Jewish New Year? Shame on you!

Posted by: anon | Sep 23, 2006 10:39:28 AM

The comments to this entry are closed.

Recent Posts

December 2008
Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      


Complete Archives List



Category Cloud

On the Nightstand

On the Nightstand

 Subscribe in a reader

Get The Big Picture!
Enter your email address:

Read our privacy policy

Essays & Effluvia

The Apprenticed Investor

Apprenticed Investor

About Me

About Me
email me

Favorite Posts

Tools and Feeds

AddThis Social Bookmark Button

Add to Google Reader or Homepage

Subscribe to The Big Picture

Powered by FeedBurner

Add to Technorati Favorites


My Wishlist

Worth Perusing

Worth Perusing

mp3s Spinning

MP3s Spinning

My Photo



Odds & Ends

Site by Moxie Design Studios™